Scientists at ETH Zurich and Roche have developed a completely new method for the analysis of molecules in liquids on a chip. The possible applications of this technology are immense. It has the potential, inter alia, to revolutionise medical diagnostics.
Much can be detected in blood or urine: viral illnesses, metabolic disorders or autoimmune diseases can be diagnosed with laboratory tests, for instance. But such examinations often take a few hours and are quite complex, which is why doctors hand the samples over to specialist laboratories.
Scientists at ETH Zurich and the company Roche have jointly developed a completely new analysis method based on light diffraction on molecules on a small chip. The technique has the potential to revolutionise diagnostics: in future, physicians may be able to perform complex examinations easily and quickly in their own practice.
Directly visible with laser light
As with other established diagnostic procedures, the new method also uses the key-lock principle of molecular recognition: for instance, in order to determine a particular protein dissolved in the blood (the “key”), it must dock on to a suitable antibody (the “lock”). In established immunological test methods, the “key in the lock” is made visible with a second colour-coded key, but this step is no longer necessary in the new process – the “key in the lock” can be made visible directly with a laser light.
The scientists use a chip with a specially coated surface made up of tiny dots with a specific striped pattern. The molecules in question bind to the stripes but not to the interstices between the stripes. If a laser light is now directed along the chip’s surface, it is bent (diffracted) as a result of the special arrangement of the molecules in the pattern and focused on to a point below the chip. A point of light becomes visible. When the scientists put samples without the molecules on to the chip, the light is not bent and no point of light is visible.
“The point of light is an effect of the interplay of hundreds of thousands of molecules in their specific arrangement,” says Christof Fattinger, a scientist at Roche. “As with a hologram, the wave character of the laser light is used in a targeted manner.”
Janos Vörös, professor of bioelectronics at ETH Zurich, compares the principle to an orchestra: “The molecules are the musicians, the stripe pattern the conductor. It ensures that all the musicians work in concert.” The scientists call the striped pattern “mologram” (molecular hologram) and the new diagnostic technique “focal molography”.
Fattinger invented the principle and developed its theoretical foundations. Five years ago, he took a sabbatical in the group led by Vörös; the practical implementation of molography has now emerged from that collaboration between the Roche scientists and ETH Zurich.
Other molecules do not disrupt
A significant advantage of the new method is that the signal (the point of light) comes about only because of the molecules that bind specifically to the mologram – other molecules present in a sample do not produce a signal. The method is therefore substantially faster than previous analysis methods based on the key-lock principle. In the latter, other molecules present in a sample have to be washed away, which in turn slows down and complicates the diagnosis. This makes the new method ideal for measuring proteins in blood or other bodily fluids.
“We expect that this technology will enable more laboratory tests to be performed directly in the doctors’ office in the future rather than in a specialist laboratory. And in the distant future, patients may even be able to use the technology at home,” says Vörös.
Several molograms are arranged on a small chip. In the current design, 40 molograms measure the same molecule, but in future it may be possible to measure 40 or more different markers simultaneously on a chip.
The possible applications of this new technique are immense. It could be used wherever the interaction between molecules needs to be identified and investigated. The method is so fast that it is even suitable for real-time measurements, which is of particular interest for basic biological research: for example, to examine how quickly one biochemical molecule binds to another. Further applications might include quality control for drinking water treatment or process monitoring in the biotechnological industry.
Intense focus on market readiness
“The fact that we were successful in putting the idea into practice is due largely to the fact that our project team is interdisciplinary,” says Vörös. Among the participants were experts in photochemistry, chip manufacturing and surface coating. The scientists also used special coating polymers for the mologram, which were developed recently in the laboratory of ETH professor Nicholas Spencer (ETH News reported). “Without these polymers and without the collaboration with Janos Vörös, we would still be far from our goal,” says Fattinger.
In order to develop the method further, the collaboration between Roche and ETH Zurich will continue. While several scientists and doctoral students in the Vörös’ group are working on its scientific aspects, the partners also plan to explore commercialisation opportunities for various applications.
Learn more: Holograms for molecules
The Latest on: Medical diagnostics
- GCC Diagnostic Imaging Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025on January 24, 2021 at 11:25 pm
Selbyville, Delaware According to the research report titled 'GCC Diagnostic Imaging Market Analysis, 2020', available with Market Study Report LLC, GCC diagnostic imaging market is expected to ...
- $2.88 Billion in Sales Expected for Quest Diagnostics Incorporated (NYSE:DGX) This Quarteron January 24, 2021 at 10:32 pm
Wall Street analysts expect Quest Diagnostics Incorporated (NYSE:DGX) to report $2.88 billion in sales for the current quarter, according to Zacks. Seven analysts have made estimates for Quest ...
- 'It gives me my child back' | Cedar Park mom credits medical marijuana for helping her son live a better life after rare disease diagnosison January 24, 2021 at 6:26 pm
A Cedar Park mother and Texas Original Compassionate Cultivation are working to encourage legislators to remove restrictions on qualifying conditions and more.
- Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by BKD Wealth Advisors LLCon January 24, 2021 at 3:31 am
BKD Wealth Advisors LLC boosted its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX) by 20.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...
- Quest Diagnostics Incorporated (NYSE:DGX) Shares Acquired by Pacer Advisors Inc.on January 24, 2021 at 1:58 am
Pacer Advisors Inc. lifted its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX) by 93.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and ...
- How Itamar Medical Stock Could Tripleon January 23, 2021 at 6:46 am
This $356 million market cap sleep apnea company is betting it can triple its market cap. If history is any guide, it will return nearly 30% a year.
- COVID-19 Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast - ResearchAndMarkets.comon January 22, 2021 at 5:42 am
The “The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast” report has been added to ResearchAndMarkets.com’s offering. This new report quantifies the impact ...
- Sesok-Pizzini named chief medical officer of LabCorp Diagnostics as Adcock retireson January 19, 2021 at 11:41 am
Laboratory Corporation of America Holdings, the Burlington-based life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed as chief medical officer of LabCorp ...
- Medical technology provider Hillrom buying Bardy Diagnostics for $375 millionon January 19, 2021 at 6:28 am
Medical technology company Hillrom said it's acquired Bardy Diagnostics Inc. for $375 million in cash. Chicago-based Hillrom (NYSE: HRC) said Seattle-based Bardy Diagnostics (BardyDX) makes digital ...
- Diagnostic/Medical Imaging Market Emerging Technologies and Sales Revenue 2031on January 18, 2021 at 9:52 pm
According to new reliable research on Diagnostic/Medical Imaging Market (2022-2031), featuring a short universal view of the size of the market, geographical scope and key trends based on volume and ...
via Google News and Bing News